2SCHELLEKENS G A,VISSER H,de JONG RAW, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide[J]. Arthrit Rheum,2000,43(1) :155-163.
3KROOT E J,de JONG B A,van LEEUWEN M A, et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis[J]. Artbritis Rheum, 2000,43(8) :1831-1835.
4娄玉铃.风湿病诊断治疗学[M].郑州:郑州大学出版社,..
5NICOLA B,GIOVANNI M,ELIO S, et al. Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis[J].Clin Chem,2001,47(7): 1089-1093.
6Bukhari M, Hanison B, Lunt M, et al. Time to first occurrence of erosions in inflammatory polyarthritis: results from a prospective community-based study. Arthritis Rheum, 2001, 44: 1248- 1253.
7Schellekens GA, Visser H, de Jong BAW, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum, 2000, 43: 155-163.
8Schellekens GA, de Jong BA, van den Hoogen FHJ, et al. Citrulline is an essential consistent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest, 1998, 101: 273-281.
9Girbal-Neuhuaser E, Durieux JJ, Aamaud M, et al. The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro) filaggrin by deamination of arginine residues. J Immunol, 1999, 162: 585-594.
10Grootenboer-Mignot S, Nicaise-Roland P, Delaunay C, et al Second generation anti-cyclic citrullinated peptied (anti-CCP2) antibodies can replace other anti-filaggrin antibodies and improve rheumatoid arthritis diagnosis. Scand J Rheumatol, 2004, 33:218-220.
